Chun Chun Tang

Direttore/Membro del Consiglio presso StemCyte, Inc.

Health Technology

Profilo

Chun Chun Tang is currently a Director at StemCyte, Inc. since 2014.
Prior to this, Mr. Tang was the Chairman, General Manager & Spokesman at Fountain Biopharma, Inc.

Posizioni attive di Chun Chun Tang

Società	Posizione	Inizio
StemCyte, Inc. StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA.	Direttore/Membro del Consiglio	17/04/2014

Tutte le posizioni attive di Chun Chun Tang

Precedenti posizioni note di Chun Chun Tang

Società	Posizione	Fine
FOUNTAIN BIOPHARMA INC	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Chun Chun Tang

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Chun Chun Tang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
StemCyte, Inc. StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA.	Health Technology
Fountain Biopharma, Inc. Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan.	Health Technology